On the 28th, the reporter learned from Wuhan Central Hospital that the hospital plans to establish Hubei's first immune cell therapy research center within three years, and gradually apply cellular immunotherapy to various types of refractory tumors, diabetes, hepatitis, chronic infections, etc. Treatment of clinically intractable and severe cases.
On the afternoon of December 27th, at the ceremony of the Houhu Campus of Wuhan Central Hospital, Dr. Liu Dongfang from the Wesley Institute of Cornell University School of Medicine and the National Youth “Thousand Talents Program†was appointed as Huazhong University of Science and Technology. Dr. Liu Dongfang, Director of the Center for Immunocycosis Therapy of Wuhan Central Hospital affiliated to Tongji Medical College, is also a professor at Tongji Medical College of Huazhong University of Science and Technology.
It is reported that in order to build a cell therapy research center, Wuhan Center Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology introduced Liu Dongfang, an internationally renowned scholar, as the director of the Center for Immunocytotherapy. Liu Dongfang currently works at Cornell University Medical Affiliated Hospital and is engaged in research on immune cell therapy. He has published more than 20 high-quality academic papers in world-class academic journals such as Nature Immunology, Immunity, and PNAS. At the same time, a series of research results have been achieved in basic immunization research. In recent years, he has presided over a number of major scientific research projects such as the National Institutes of Health and Celgene, and has been selected into the twelfth batch of national youth “Thousand Talents Programâ€.
In September this year, Wuhan Central Hospital officially listed "Wuhan Central Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology" and "The Fifth Clinical College of Tongji Medical College of Huazhong University of Science and Technology". The plan to build an immune cell therapy research center is also an increase in the hospital. An important measure in the construction of hospital disciplines.
In the next few years, in addition to vigorously introducing technical talents and scientific research teams, Wuhan Central Hospital will establish GMP cell production workshops and immune cell therapy laboratories according to international standards. After the establishment of the Cell Therapy Research Center, it will conduct scientific and clinical research and prospective treatment in accordance with the relevant provisions of the national policy.
Shenzhen Sunson Tech Co., Ltd , https://www.sunsonkiosk.com